Article

Brain Apolipoprotein E: an Important Regulator of Food Intake in Rats

Cincinnati Obesity Research Center, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
Diabetes (Impact Factor: 8.1). 07/2008; 57(8):2092-8. DOI: 10.2337/db08-0291
Source: PubMed

ABSTRACT

The worldwide prevalence of obesity is increasing at an alarming rate, along with the associated increased rates of type 2 diabetes, heart disease, and some cancers. While efforts to address environmental factors responsible for the recent epidemic must continue, investigation into the anorectic functions of potential molecules we present here, such as apolipoprotein (apo)E, offers exciting possibilities for future development of successful anti-obesity therapies.
Changes in feeding behavior after intracerebroventricular injection of apoE, the regulation of hypothalamic apoE gene expression by energy status, and the interaction of hypothalamic apoE with other neuropeptides were studied.
Intracerebroventricular apoE significantly decreased food intake without causing malaise, whereas intracerebroventricular infusion of apoE antiserum stimulated feeding, implying that endogenous apoE tonically inhibits food intake. Consistent with this, apoE was present in the hypothalamus, a brain site intimately involved in the integration of signals for energy homeostasis. Fasted rats exhibited significantly decreased apoE gene expression in the hypothalamus, and refeeding of these rats for 4 h evoked a significant increase of hypothalamic apoE mRNA levels. Both genetically obese (ob/ob) mice and rats with high-fat diet-induced obesity had significantly reduced hypothalamic apoE mRNA levels compared with their lean control counterparts, suggesting that decreased apoE may contribute to hyperphagia in these obese animals. Additionally, apoE-stimulated hypothalamic proopiomelanocortin gene expression and SHU9119, a melanocortin 3/4 receptor antagonist, attenuated the inhibitory function of apoE on feeding.
These data demonstrate that apoE suppresses food intake via a mechanism enhancing melanocortin signaling in the hypothalamus.

Full-text preview

Available from: PubMed Central
  • Source
    • "Interests in alpha-synuclein and food intake have increased[92][93]and its relevance to p53 transcriptional regulation has been shown with LPS involvement[78][79]. LPS regulation of apo E (23) has become important with relevance to apo E suppression of food intake[115][117]and LPS effects on leptin synthesis may determine appetite regulation[118][119]. Leptin is a 16 kda protein identified in 1994 (14) is synthesized by fat cells and acts as a satiety factor at the hypothalamus mediated through the leptin receptor. The amount of leptin released is proportional to the size of adipose tissue and regulates food intake. "

    Full-text · Article · Jan 2016 · Advances in Aging Research
  • Source
    • "Apolipoprotein E (ApoE) is a protein that is predominantly produced in the liver and brain. In addition to its role in lipid metabolism, ApoE is also recognized as a physiological suppressor of food intake, which leads to body weight loss, because the targeted deficiency of ApoE was previously reported to significantly elevate food intake and body weight gain in mice (Schreyer et al., 2002; Shen et al., 2008). However, the molecular mechanisms underlying the ApoE-mediated modulation of body weight have not yet been elucidated. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The biological activities of cannabidiol (CBD), a major non-psychotropic constituent of the fiber-type cannabis plant, have been examined in detail (e.g., CBD modulation of body weight in mice and rats). However, few studies have investigated the biological activities of cannabidiol-2’,6’-dimethyl ether (CBDD), a dimethyl ether derivative of the parent CBD. We herein focused on the effects of CBDD on body weight changes in mice, and demonstrated that it stimulated body weight gain in apolipoprotein E (ApoE)-deficient BALB/c. KOR/Stm Slc-Apoeshl mice, especially between 10 and 20 weeks of age.
    Full-text · Article · Nov 2015 · The Journal of Toxicological Sciences
  • Source
    • "These functions include antiatherogenic effects through promotion of cholesterol efflux in macrophages [2] [3], neuronal repair and synaptogenic activity [4] [5], as well as adipocyte differentiation and lipid storage in adipose tissue [6]. Interestingly, APOE is also expressed in the hypothalamus and olfactory bulb, suggesting involvement in appetite and regulation of food intake [7] [8]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: ScopeOf the three human apolipoprotein E (APOE) alleles, the ε3 allele is most common, which may be a result of adaptive evolution. In this study, we investigated whether the APOE genotype affects body weight and energy metabolism through regulation of fatty acid utilization.Methods and resultsTargeted replacement mice expressing the human APOE3 were significantly heavier on low- and high-fat diets compared to APOE4 mice. Particularly on high-fat feeding, food intake and dietary energy yields as well as fat mass were increased in APOE3 mice. Fatty acid mobilization determined as activation of adipose tissue lipase and fasting plasma nonesterified fatty acid levels were significantly lower in APOE3 than APOE4 mice. APOE4 mice, in contrast, exhibited higher expression of proteins involved in fatty acid oxidation in skeletal muscle.Conclusion Our data suggest that APOE3 is associated with the potential to more efficiently harvest dietary energy and to deposit fat in adipose tissue, while APOE4 carriers tend to increase fatty acid mobilization and utilization as fuel substrates especially under high-fat intake. The different handling of dietary energy may have contributed to the evolution and worldwide distribution of the ε3 allele.
    Full-text · Article · Nov 2014 · Molecular Nutrition & Food Research
Show more